Centrally administered galanin reduces dopamine utilization in the median eminence and increases dopamine utilization in the medial neostriatum of the male rat.
Jansson
A
A
Department of Histology and Neurobiology, Karolinska Institutet, Stockholm, Sweden.
Fuxe
K
K
Eneroth
P
P
Agnati
L F
LF
D000818:Animals; D003342:Corpus Striatum / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D019004:Galanin; D007276:Injections, Intraventricular; D008297:Male; D008473:Median Eminence / Q000378:metabolism*; D010455:Peptides / Q000008:administration & dosage*; D051381:Rats; D011919:Rats, Inbred Strains
D010455:Peptides; D019004:Galanin; D004298:Dopamine